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Although skin and soft tissue infections (SSTI) are the most common focal infections
associated with invasive disease caused by Streptococcus pyogenes (Lancefield Group
A streptococci - GAS), there is scarce information on the characteristics of isolates
recovered from SSTI in temperate-climate regions. In this study, 320 GAS isolated
from SSTI in Portugal were characterized by multiple typing methods and tested for
antimicrobial susceptibility and SpeB activity. The covRS and ropB genes of isolates
with no detectable SpeB activity were sequenced. The antimicrobial susceptibility profile
was similar to that of previously characterized isolates from invasive infections (iGAS),
presenting a decreasing trend in macrolide resistance. However, the clonal composition
of SSTI between 2005 and 2009 was significantly different from that of contemporary
iGAS. Overall, iGAS were associated with emm1 and emm3, while SSTI were associated
with emm89, the dominant emm type among SSTI (19%). Within emm89, SSTI were
only significantly associated with isolates lacking the hasABC locus, suggesting that
the recently emerged emm89 clade 3 may have an increased potential to cause SSTI.
Reflecting these associations between emm type and disease presentation, there were
also differences in the distribution of emm clusters, sequence types, and superantigen
gene profiles between SSTI and iGAS. According to the predicted ability of each emm
cluster to interact with host proteins, iGAS were associated with the ability to bind
fibrinogen and albumin, whereas SSTI isolates were associated with the ability to bind
C4BP, IgA, and IgG. SpeB activity was absent in 79 isolates (25%), in line with the
proportion previously observed among iGAS. Null covS and ropB alleles (predicted to
eliminate protein function) were detected in 10 (3%) and 12 (4%) isolates, corresponding
to an underrepresentation of mutations impairing CovRS function in SSTI relative to iGAS.
Overall, these results indicate that the isolates responsible for SSTI are genetically distinct
from those recovered from normally sterile sites, supporting a role for mutations impairing
CovRS activity specifically in invasive infection and suggesting that this role relies on a
differential regulation of other virulence factors besides SpeB.
Keywords: Streptococcus pyogenes, skin and soft tissue infections, emm89, covRS, SpeB, ropB, emm clusters,
antimicrobial resistance
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INTRODUCTION
Streptococcus pyogenes (group A streptococcus, GAS) is
responsible for a variety of human infections ranging from
mild and frequent diseases, such as pharyngitis and cutaneous
infections, to more severe and rare invasive infections including
sepsis, necrotizing fasciitis and streptococcal toxic shock
syndrome (Walker et al., 2014). In 2005, the estimated global
incidence of invasive GAS infections (iGAS) was 663,000 new
cases, resulting in 163,000 deaths, while at least 111 million
children under 15 years suffered from pyoderma, mostly in
developing countries, and pharyngitis incidence was estimated at
over 616 million cases (Carapetis et al., 2005). Even though mild
infections are usually self-limited, they may play a crucial role
in transmission. Furthermore, the nasopharyngeal mucosa and
the skin can also be asymptomatically colonized representing
primary reservoirs of GAS (Cunningham, 2000).
The gold-standard typingmethodology of GAS is emm typing,
which relies on the variability of the amino acid sequence of
the N-terminal portion of S. pyogenes major virulence factor:
the M protein (McMillan et al., 2013). The sequence of the
5′ variable region of the emm gene encoding the M protein
determines the emm type, of which there are more than 250
distinct variants (https://www.cdc.gov/streplab/m-proteingene-
typing.html). However, emm typing is based on the sequence
of only approximately 10–15% of the complete emm gene.
Recently a new classification was proposed based on emm clusters
established by phylogenetic analysis of the entire sequence of
the emm gene of 175 different emm types (Sanderson-Smith
et al., 2014). Each cluster contains isolates with closely related
M proteins that share binding motifs to host proteins and other
structural properties. Since isolates with the same emm type
encode nearly identical M proteins, the emm cluster can be
inferred from the emm type.
Associations between certain emm types and specific disease
presentations have been established. Of particular importance
is the association of iGAS with a contemporary emm1 clone,
frequently designated as M1T1, which has persisted for decades
as themajor cause of invasive disease inmost developed countries
(O’Loughlin et al., 2007; Aziz and Kotb, 2008; Luca-Harari et al.,
2009; Friães et al., 2012). Recently, the emergence of a specific
emm89 clade (clade 3) that rapidly outcompeted the previously
circulating emm89 strains was reported in multiple countries
and associated with an increase in the prevalence of emm89
among GAS infections (Friães et al., 2015a; Turner et al., 2015;
Zhu et al., 2015). Isolates from clade 3 are characterized by
the absence of the hasABC locus encoding the hyaluronic acid
capsule of GAS, and by a variant nga-ifs-slo locus, similar to the
one present in M1T1 strains, which is associated with increased
expression of NAD-glycohydrolase (NADase) and streptolysin O
(SLO) (Turner et al., 2015; Zhu et al., 2015).
Despite the success of emm typing, some studies have
suggested it is not enough to identify GAS clones and that
it must be complemented with other typing methods such
as multilocus sequence typing (MLST), superantigen (SAg)
gene profiling (Carriço et al., 2006; Friães et al., 2013a), and,
more recently, whole genome sequencing (Carriço et al., 2013).
However, variability in key virulence factors and regulators
within clones defined by these typing methods may have
important consequences for the virulence of a particular isolate.
A mouse model of skin and soft tissue infection (SSTI)
showed that mutations in the covRS two component system
were a key step for the transition from a localized to a systemic
infection (Sumby et al., 2006). Consistently, several studies
reported covRS mutations in isolates recovered from human
infections (Engleberg et al., 2001; Hasegawa et al., 2010; Ikebe
et al., 2010; Lin et al., 2014; Friães et al., 2015b). In these isolates
the downregulation of SpeB expression, a potent extracellular
cysteine protease, is thought to be fundamental toward the switch
to a hipervirulent phenotype (Aziz et al., 2004; Kansal et al.,
2010). Transcription of speB is also under direct control of RopB
(Carroll and Musser, 2011), and naturally occurring mutations
in ropB were also shown to impair SpeB production (Hollands
et al., 2008; Carroll et al., 2011). We reported previously that
mutations resulting in the truncation of CovS, which presumably
impaired its function, were significantly overrepresented among
iGAS compared to pharyngitis in Portugal. However these were
only present in 10% of invasive isolates, not explaining why
most isolates caused invasive infections. Additionally, among all
studied isolates, which included invasive and pharyngeal isolates,
20% had no detectable SpeB activity but no significant association
was detected between the presence or absence of SpeB activity
and the type of infection (Friães et al., 2015b).
In order to cause a wide spectrum of disease, GAS has to
be able to adapt to different environments in the host and
despite decades of research there is still no consensus regarding
which molecular or phenotypic properties are responsible for
an enhanced invasive potential of certain lineages. Although the
nasopharyngeal mucosa is usually considered as the main source
of isolates causing iGAS in developed countries (Fiorentino et al.,
1997), SSTI are commonly reported as the predominant foci
associated with invasive disease (Lamagni et al., 2008). This
raises the possibility that strains adapted to infect the skin have
an increased ability to invade and survive in deeper tissues.
However, there is scarce data about the characteristics of GAS
isolates responsible for SSTI, especially in developed, temperate
climate regions. Most of the studies from these regions report
the characteristics of SSTI isolates together with GAS from other
non-invasive sites (mostly pharyngeal swabs) when comparing
invasive and non-invasive disease (Descheemaeker et al., 2000;
Ekelund et al., 2005; Rivera et al., 2006). A few others specify
the molecular characteristics of the SSTI isolates subset, but are
limited in the number of isolates or are restricted to short time
periods (Kittang et al., 2008; Mijač et al., 2010; Vähäkuopus
et al., 2012; Tamayo et al., 2014). In this study we characterized
320 isolates from SSTI recovered in Portugal during 2003–
2009 for their susceptibility to a panel of antimicrobials, emm
type, SAg profile, and MLST. The genes conferring resistance
to selected antimicrobials were also investigated. In addition, all
320 isolates were tested for SpeB activity and in those without
detectable activity we sequenced the covRS and ropB genes
to document any mutations. The SSTI isolates from 2005 to
2009 presented substantial differences relative to a collection
of previously partially characterized iGAS isolates recovered in
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the same period in Portugal (Friães et al., 2007, 2013b). The
prevalence of mutations impairing CovRS function was found to
be lower when compared with that previously reported among
iGAS isolates in Portugal (Friães et al., 2015b).
METHODS
Bacterial Isolates
For this study, 24 hospital laboratories distributed throughout
Portugal were asked to send us, on a voluntary basis, all
GAS isolated from SSTI between January 2003 and December
2009. The study was approved by the Institutional Review
Board of the Centro Académico de Medicina de Lisboa. These
were considered surveillance activities and were exempt from
informed consent. All methods were performed in accordance
with the relevant guidelines and regulations. The data and
isolates were de-identified so that these were irretrievably
unlinked to an identifiable person. Participation was low in
the first 2 years (n = 17 in 2003, n = 8 in 2004), but
subsequently increased (average n = 59/year, range 48–77)
(Dataset 1 available at http://dx.doi.org/10.6084/m9.figshare.
6736313). Overall, 320 non-duplicate GAS isolates from SSTI
were recovered and included in the study: 306 from skin and
soft tissue exudates (pus) and 14 from skin and soft tissue
biopsies. Identification of isolates was performed by colony
morphology, β-hemolysis on blood agar, and the presence of the
characteristic Lancefield group A antigen (OXOID, Basingstoke,
UK). In addition, 247 non-duplicate iGAS isolates recovered in
the same hospitals during 2005–2009, which had been partially
characterized previously (Friães et al., 2007, 2013b), were also
included (Dataset 2 available at http://dx.doi.org/10.6084/m9.
figshare.7016663). Strain SF370 was obtained from Colección
Española de Cultivos Tipo (CECT5109). Strains were grown at
37◦C in Todd Hewitt broth (THB) (BD, Sparks, MD, USA) or in
Tryptone Soy Agar (Oxoid, Basingstoke, UK) supplemented with
5% defibrinated sheep blood.
Antimicrobial Susceptibility Testing and
Genetic Determinants
Susceptibility tests were performed by disk diffusion according
to the guidelines of the Clinical and Laboratory Standards
Institute (CLSI) (Clinical Laboratory Standards Institute,
2017) for penicillin, vancomycin, erythromycin, levofloxacin,
tetracycline, chloramphenicol, clindamycin and linezolid
(Oxoid, Basingstoke, UK). E-test strips (BioMérieux, Marcy
l’Etoile, France) were used for MIC determination in cases
of intermediate susceptibility and to confirm resistance
when ≤5 isolates were resistant to a particular antimicrobial.
Determination of macrolide resistant phenotype was performed
as previously described (Melo-Cristino and Fernandes, 1999).
A multiplex PCR reaction for erm(B), erm(A), and mef genes
was used on macrolide resistant isolates to identify the resistance
conferring genes (Figueira-Coelho et al., 2004). Themef positive
isolates were further analyzed in order to distinguish between
mef (A) and mef (E) (Silva-Costa et al., 2008). The tetracycline
resistance genotype was determined for resistant isolates by a
multiplex PCR for the genes tet(K), tet(L), tet(M) and tet(O)
(Trzcinski et al., 2000).
Molecular Typing
The emm typing was performed according to the protocols
and recommendations of the Center for Disease Control
and Prevention (CDC) (https://www.cdc.gov/streplab/protocol-
emm-type.html).
The presence of 11 SAg genes (speA, speC, speG, speH, speI,
speJ, speK, speL, speM, smeZ, and ssa) was tested by two multiplex
PCR reactions using the amplification of speB and speF gene
fragments as positive controls (Friães et al., 2013a). Absence of
a PCR product for speB and speF was confirmed by Southern
blotting as previously described (Friães et al., 2013a).
MLST analysis was performed for all SSTI isolates (n = 320),
as well as for the iGAS isolates that had not been previously
typed by MLST (n = 135/247) (Friães et al., 2007, 2012, 2013b).
Allele and sequence type (ST) identification was done using the
S. pyogenesMLST database (https://pubmlst.org/spyogenes/).
The sequence of the covRS and ropB loci of all SSTI
isolates that presented no proteolytic activity (see below) was
determined as previously described (Friães et al., 2015b). For each
isolate, the sequences were assembled and compared with the
corresponding regions of the genome of strain SF370 (GenBank
AE004092), considered as the reference wild-type alleles. Isolates
were considered to carry null alleles if the changes found were
predicted to result in absence of a functional protein due to
nonsense mutations or frameshifts. All new covRS and ropB
sequences identified in this study were deposited in GenBank
(accession numbers MH537795-MH537849).
Determination of Proteolytic Activity and
SpeB Expression
All isolates were screened for detectable SpeB activity using
a plate assay, as previously described (Friães et al., 2015b).
Briefly, single GAS colonies were stab-inoculated into fresh plates
of medium containing 0.5-strength Columbia broth, 3% w/v
skim milk (BD, Sparks, MD, USA), and 1% w/v agar (Oxoid,
Basingstoke, UK). A strain was considered to show proteolytic
activity when it presented a translucent zone of size similar to
the one of strain SF370 after 24h incubation at 37◦C, in three
independent assays. On the contrary, a strain was considered not
to show proteolytic activity if it did not produce a translucent
halo in any of the three assays. For strains in which the results
of the three assays were inconclusive or not consistent, detection
of SpeB by Western blot was performed (Friães et al., 2015b) and
this was considered the final result.
Statistical Analysis
Simpson’s index of Diversity (SID) with respective 95%
confidence intervals (CI95%) was used for the analysis of the
typing methodologies and to evaluate the allelic diversity of the
covR, covS, and ropB genes found in this study (Carriço et al.,
2006). Two-tailed Fisher’s exact test and odds ratios were used
to identify significant pairwise associations. Overall differences
in the distribution of typing characteristics between infection
types was evaluated by the χ2-test. The Cochran-Armitage test
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was used to evaluate trends. Only characteristics grouping ≥10
isolates were considered in statistical tests, with all other isolates
grouped together in a single group. The p-values for multiple
tests were corrected using the false-discovery rate (FDR) linear
procedure (Benjamini and Hochberg, 1995). A p-value < 0.05
was considered significant for all tests.
RESULTS
Antimicrobial Susceptibility and Genotypic
Determinants of Resistance
All 320 SSTI isolates analyzed (Dataset 1) were susceptible to
penicillin, vancomycin, and linezolid. Two isolates were non-
susceptible to levofloxacin (MIC= 6 mg/mL and 3 mg/mL, both
emm89). One was resistant to chloramphenicol (emm147).
Macrolide resistance was detected in 33 SSTI isolates (10%)
of 12 different emm types (Dataset 1), with a significant
decreasing trend during the years of the study (p < 0.001)
(Supplementary Figure 1). The majority of these isolates
presented the cMLSB phenotype (constitutive resistance to both
erythromycin and clindamycin) and carried the erm(B) gene
(n = 22). The remaining macrolide resistant isolates (n = 11)
exhibited the M phenotype (resistance to erythromycin and
susceptibility to clindamycin) and carried the mef (A) gene,
except for one isolate that was positive for themef (E) gene.
Tetracycline resistance was detected in 47 SSTI isolates
(15%) comprising 25 emm types (Dataset 1) with no significant
temporal trend (Supplementary Figure 1). The majority of these
isolates (n = 42) presented only the tet(M) gene, while three
isolates carried both tet(M) and tet(L) and two isolates presented
solely the tet(O) gene. Resistance to tetracycline and macrolides
was simultaneously detected in 12 isolates, of which 9 presented
the cMLSB phenotype.
emm Typing
A total of 51 different emm types were identified among SSTI
isolates (Table 1). Isolates with emm89 were the most frequently
recovered (n = 62, 19%), followed by emm1 (n = 55, 17%),
together accounting for 36% of all SSTI isolates (Figure 1).
The emm types were distributed into 15 emm clusters (Table 1
and Figure 1). The majority of SSTI isolates belong to emm
clusters from clade X (n= 189, 59%).
The characteristics of SSTI isolates were compared with
those from contemporary iGAS isolates. Given the reduced
number of SSTI isolates in the first 2 years of the study,
this comparison was performed only for the SSTI and iGAS
isolates recovered from 2005 to 2009 (Dataset 1 and Dataset 2).
Significant differences were detected in the overall distribution
of emm types (p < 0.001), as well as in the prevalence of
specific emm types (Supplementary Figure 2) with the SSTI
subset presenting a higher SID than the iGAS subset (Table 1,
p= 0.014). In agreement, 24 emm types accounting for 36 isolates
were identified exclusively among SSTI, while seven emm types
accounting for seven isolates were found only in iGAS. While
emm1 and emm3 were significantly overrepresented among iGAS
(p < 0.001 and p = 0.002, respectively), emm89 was significantly
overrepresented among SSTI (p = 0.006). However, when
TABLE 1 | Simpson’s Index of Diversity (SID) and respective 95% confidence
intervals for emm type, emm cluster, superantigen (SAg) profile, and sequence



































a Isolates with no emm cluster (SSTI, n = 3, emm types 127, 147 and 167; iGAS, n = 3,
emm types 196, 199, and stG1750) were not considered for SID determination.
stratifying the emm89 isolates as to the presence or absence of the
hasABC locus (Friães et al., 2015a) (Dataset 1), only the isolates
lacking the locus were associated with SSTI (p = 0.028). All
these differences were still significant after FDR correction.When
exploring possible changes in time from 2005 to 2009, there
was a significant increase of emm89 among SSTI (p = 0.012),
while among iGAS the increase of emm89 was not statistically
supported after FDR (Dataset 1 and Dataset 2). In both infection
types, this was underpinned by an increase in the proportion of
the acapsular emm89 isolates (p < 0.001), while there was no
significant change in time of emm89 isolates with the hasABC
locus in either infection type.
The differences of emm types were reflected in the distribution
of emm clusters among SSTI and iGAS isolates (Figure 1),
although the SIDs were not significantly different (Table 1,
p = 0.910) While iGAS isolates were significantly associated
with emm clusters A-C3 (comprising almost exclusively emm1
isolates) and A-C5 (comprising exclusively emm3 isolates) (p
< 0.001 and p = 0.002, respectively), SSTI isolates were
significantly associated with emm cluster E4 (dominated by
emm89) (p= 0.006).
The emm cluster typing system can be used for predicting
the ability of the strains to bind different host proteins
based on the binding properties of the respective M proteins
(Supplementary Table 1) (Sanderson-Smith et al., 2014). When
comparing SSTI and iGAS isolates, and excluding the clusters
with uncertain binding for each host protein, the ability to
bind C4BP was associated with SSTI isolates (p < 0.001). This
association reflects the high prevalence of clusters E3 and E6
among SSTI, even though the dominant cluster among SSTI
(cluster E4) was classified as uncertain in the ability to bind C4BP.
SSTI isolates were also associated with the ability to bind IgA and
IgG (p= 0.002 and p= 0.033, respectively), whereas the invasive
isolates were associated with the ability to bind fibrinogen and
albumin (p < 0.001 and p = 0.004, respectively), all significant
after FDR.
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FIGURE 1 | Distribution of isolates recovered from skin and soft tissue infections (SSTI) and invasive infections (iGAS) according to emm cluster and emm type. Only
emm clusters with a total of ≥10 isolates in both infection types are represented. Numbers inside the bars represent the emm types included in each cluster. Black
bars include emm types with < 3 isolates [SSTI, E4: emm77, emm102, and emm109 (each n = 1); E3, emm82, emm103, emm168, and emm209 (each n = 1); D4,
emm70 and emm223 (each n = 2), emm33, emm43, emm80, emm83, emm93, and emm225 (each n = 1); E6:,emm65, emm81, and emm94 (each n = 1). iGAS,
E4, emm77 (n = 2), emm2, and emm84 (each n = 1); A-C3: emm227 (n = 1); E3,emm58 and emm103 (each n = 2), emm9 and emm118 (each n = 1); E1, emm78
(n = 2); E6, emm75 and emm81 (each n = 1)]. *p ≤ 0.01.
MLST
The studied SSTI isolates comprised 70 different STs
(Tables 1, 2). A total of 20 new STs were found among
the SSTI and iGAS isolates typed in this study (ST817-
ST836), including two new alleles for gtr (108; 109),
three for murI (105-107), two for mutS (88; 89), two for
recP (125;126), two for xpt (102; 103), and three for yqil
(119-121).
In the period of 2005–2009, the overall distribution of STs
differed significantly between SSTI and iGAS (p < 0.001),
with a higher diversity among SSTI (Table 1, p = 0.002).
ST28 and ST15 were associated with iGAS (p < 0.001
and p = 0.007, respectively) (Supplementary Figure 3),
in agreement with the association of the corresponding
dominant emm types with iGAS (emm1 for ST28 and
emm3 for ST15). These differences were supported after FDR
correction.
No significant differences were detected when comparing the
ST diversity of isolates with the same emm type recovered from
each type of infection (Table 2).
SAg Profiling
Overall, chromosomally encoded smeZ and speG genes were the
most frequently detected among SSTI isolates, being present in
307 (96%) and 301 (94%) isolates, respectively (Table 3). PCR-
amplification of speB and speF was not possible for one isolate,
and the absence of both genes was confirmed by Southern
blot (data not shown). A total of 50 distinct SAg profiles were
identified among the SSTI isolates (Tables 1, 3).
During 2005–2009, the presence of the genes speA and
speK was significantly associated with invasive isolates (p
< 0.001 and p = 0.018, respectively), while speC, speL,
and speM were significantly associated with isolates from
SSTI (p = 0.019, p = 0.003, and p < 0.001, respectively)
(Supplementary Figure 4A).The overall distribution of SAg
profiles differed between the two types of infection (p < 0.001)
and the SAg profiles of SSTI isolates were more diverse than those
of invasive isolates (Table 1, p= 0.008). Reflecting the association
between emm type and infection and the high correlation
between emm typing and SAg profiling (Friães et al., 2013a), SAg
profiles 8 and 10, which correspond mostly to emm3 and emm1,
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TABLE 2 | Distribution of sequence types (ST) among emm types identified in skin
and soft tissue infections (SSTI) and invasive infections (iGAS) in Portugal.





1 28 (43); 643 (1); 830 (2) 28 (65); 618 (1); 643 (3)
89 101 (35); 408 (13); 824 (10) 101 (18); 408 (6); 824 (3)
6 382 (13); 411 (7) 382 (13); 411 (8)
3 15 (7); 315 (5) 15 (18); 315 (4); 406 (5)
4 38 (1); 39 (15) 39 (10); 771 (1); 823 (2)
28 52 (15) 52 (12); 458 (1); 821 (1)
44 25 (12); 178 (2); 429 (1); 555 (2) 25 (7); 178 (1); 555 (2)
12 36 (9); 467 (1) 36 (12)
87 62 (9) 62 (6)
64 164 (3) 164 (9)
11 403 (6) 403 (4); 562 (1)
5 99 (4) 99 (6)
22 46 (5); 389 (1) 46 (4)
Othersb 2 (1); 3 (2); 5 (1);10 (1); 24 (2);
50 (2); 55 (8); 60 (1); 63 (1); 75
(3); 89 (1);120 (1); 130 (3); 150
(3); 161 (7); 164 (1);166 (1); 167
(1); 184 (1); 200 (1); 253 (3); 340
(2); 341 (1); 409 (1); 565 (2); 569
(1); 573 (1); 642 (2); 701 (1); 718
(1); 754 (1); 819 (1); 820 (1); 822
(1); 825 (1); 826 (3); 827 (1); 828
(1); 829 (1); 831 (1); 833 (1); 834
(1); 835 (1); 836 (1)
28 (2); 50 (1); 55 (1); 63 (2); 75
(1); 99 (1); 150 (1); 184 (1); 201
(2); 258 (1); 402 (1); 409 (2); 410
(2); 619 (1); 769 (1); 816 (1); 818
(1), 832 (1); 833 (1)
aDoes not include SSTI isolates recovered during 2003 and 2004 (n= 25), which comprise
13 different STs: [emm1, ST28 (n= 9); emm3, ST15 (n= 1); emm4, ST38 (n= 1); emm12,
ST36 (n = 1); emm18, ST642 (n = 1); emm22, ST46 (n = 1); emm28, ST52 (n = 2);
emm44, ST25 (n = 1); emm68, ST331 (n = 1); emm73, ST331 (n = 1); emm77, ST63
(n = 1); emm89, ST101 (n = 2) and ST408 (n = 2); emm209, ST817 (n = 1)].
b“Others” include emm types with n < 10 isolates considering both SSTI (2005-2009)
and iGAS isolates (2005-2009). Those include emm types 2, 9, 18, 19, 33, 43, 48, 50,
53, 58, 65, 70, 71, 74, 75, 76, 77, 78, 80, 81, 82, 83, 84, 90, 93, 94, 102, 103, 109, 118,
122, 127, 147, 167, 179, 196, 209, 223, 225, 277, and stG1750.
respectively, were associated with iGAS (p= 0.001 and p< 0.001,
respectively), (Supplementary Figure 4B).
SpeB Protease Activity and Sequence of
covRS and ropB
We previously showed that the total proteolytic activity could be
used as a proxy for SpeB activity and that all isolates with null
alleles, either in covS or in ropB, lacked SpeB activity (Friães et al.,
2015b).
Among the 320 SSTI isolates, 79 (25%) had no detectable
SpeB activity (Dataset 1). These isolates represented 22 different
emm types [SID (CI95%) = 0.895 (0.853–0.937)] and 28 STs [SID
(CI95%)= 0.934 (0.907–0.961)].
Among the isolates with no SpeB activity, 15 distinct covR
alleles were identified, resulting in only two different amino
acid sequences, while 34 and 47 different alleles were detected
for covS and ropB, corresponding to 22 and 37 distinct amino
acid sequences, respectively (Figure 2). In two isolates no
PCR product was amplified using the ropB specific primers,
indicating a possible deletion involving the ropB gene. In
one of these isolates, the absence of PCR amplification of
the speB and speF genes, both located in the same region as
ropB, supports the occurrence of a large deletion encompassing
the entire ropB gene, as well as speB and speF. Deletions
spanning different lengths in this locus have been previously
identified in GAS isolates from human infections (Friães et al.,
2013a).
Nucleotide changes predicted to prevent the expression of
a functional protein due to nonsense mutations or frameshifts
were considered to result in null alleles. No null alleles were
detected in covR, while null covS alleles were detected in 10
isolates. Since none of the SpeB-positive isolates is expected
to have null covS alleles, these would correspond to 3% of
all isolates recovered from SSTI. These null covS alleles were
present in isolates of six different emm types (emm1, emm11,
emm89, and emm118, each n = 2; emm9 and emm223, each
n = 1) and seven STs (ST28, ST403, and ST565, each n = 2;
ST75, ST101, ST408, and ST828, each n = 1), and there
were no associations with specific emm types or STs. Two
isolates presented in-frame indels (45 bp deletion and 3 bp
insertion), whose effect on protein function is not clear. The
consequences of these in-frame indels in CovS protein function
could not be inferred based on the absence of SpeB, since both
isolates also carry null ropB alleles which could explain the
downregulation of SpeB. Therefore these were not considered
null alleles.
A total of 12 isolates presented null ropB alleles (including the
two isolates with a ropB deletion), representing 4% of all isolates,
and 15% of the isolates with no detectable SpeB. These isolates
comprised eight emm types (emm1, n = 3; emm12 and emm89,
each n = 2; emm2, emm3, emm11, emm22, and emm87, each
n= 1) and nine STs (ST28, n= 3; ST36, n= 2; ST46, ST55, ST62,
ST101, ST315, ST403, and ST408, each n= 1), with no association
to any specific emm type or ST.
Among the isolates without SpeB, a total of 22 (28%) presented
a null allele in at least one of the three genes. Forty-four SpeB-
negative SSTI isolates carry amino acid changes in covRS or ropB
whose impact on SpeB expression is difficult to predict (Olsen
et al., 2012; Friães et al., 2015b; Horstmann et al., 2015). The
remaining 13 isolates with no detectable SpeB showed the same
amino acid sequence as the reference strain for all sequenced
genes (emm71, n = 1; emm80, n = 1; emm87, n = 1; emm89,
n = 8; emm109, n = 1; emm122, n = 1). In these isolates
the absence of SpeB probably resulted from changes other than
the impairment of CovRS or RopB function, possibly due to
mutations in one of the at least 19 other genes whose products
have been shown to influence the production of an enzimatically
active SpeB (Carroll and Musser, 2011). No emm type was
associated with the absence of detectable SpeB activity and the
only ST (ST382 representing 65% of all emm6 isolates) associated
with a lack of SpeB activity (p = 0.004) presented no null
alleles at any of the sequenced loci. However, isolates of this
ST harbor multiple amino acid substitutions in both covS and
ropB genes that could contribute to the speB-negative phenotype
(Dataset 1).
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TABLE 3 | Superantigen (SAg) profiles identified in isolates recovered from skin and soft tissue infections (SSTI) in Portugal during 2003–2009.
SAg profilea speA speC speG speH speI speJ speK speL speM ssa smeZ emm type (No. of isolates)
2 + + + – – – + – – – + 6 (17); 74 (1)
3 + + + – – + – – – – + 1 (11); 87 (1)
4 + + + – – – – + + – + 18 (3); 22 (1)
5 + + + – – – – – – – + 5 (2); 11 (1); 18 (1); 122 (1)
8 + – + – – – + – – + + 3 (11)
9 + – + – – – + – – – + 6 (1)
10 + – + – – + – – – – + 1 (43); 71 (1)
11 + – + – – – – – – – + 43 (1); 82 (1)
12 – + + + + + – – – + + 44 (2)
13 – + + + + – – – – + + 22 (1)
15 – + + + – + + – – – + 28 (1)
16 – + + + + – – – – – + 11 (4); 16 (6); 48 (4)
18 – + + – – + + – – + + 87 (1)
19 – + + – – – + – – + + 22 (2)
20 – + + – – + – – – + + 84 (4)
21 – + + – – – – – – + + 22 (2)
23 – + – – – – – – – + + 4 (16)
24 – + + – – + + – – – + 28 (8)
26 – + + – – – + – – – + 89 (3)
27 – + + – – + – – – – + 28 (8); 68 (1); 70 (2); 89 (15); 90 (1)
28 – + + – – – – + + – + 75 (1)
29 – + + – – – – – – – + 5 (2); 11 (1); 48 (3); 50 (1); 77 (1); 78 (4);
89 (35); 118 (1); 127 (1)
31 – + + – – – – + + – – 2 (7)
32 – – + + + + – – – + + 44 (12)
33 – – + + + – – – – – + 12 (5); 73 (1); 76 (2)
35 – – + + – – – – – – + 75 (1); 94 (1)
38 – – + – – + – – – + + 44 (1); 87 (1); 223 (1)
39 – – + – – – – + + + + 53 (1); 75 (2)
40 – – + – – – – – – + + 90 (3); 22 (1)
41 – – – – – – – – – + + 4 (1)
43 – – + – – – + – – – + 65 (1); 209 (1)
44 – – + – – + – – – – + 102 (1); 103 (1); 118 (2); 223 (1)
45 – – + – – – – + + – + 80 (1)
46 – – + – – – – – – – + 53 (2); 58 (1); 64 (3); 75 (1); 89 (9); 118 (1);
147 (1); 167 (1); 168 (1)
47 – – – – – – – – – – + 77 (1)
48 – – + – – – – + + – – 2 (1)
51 + + + + + – + – – – + 6 (2)
52 + + + – – – + – – + + 22 (1)
53 + – + – – – – – – + + 3 (2)
54 – + + + + + – – – – + 87 (1)
56 – – + + – + – – – – – 44 (3)
60 + – + + + + – – – – + 71 (2)
61 + – + – – + + – – – + 1 (1)
64 – + + + + – – + + – + 93 (1)
66 – + + – – – – – + – + 58 (3)
67 – – + + – + – – – + + 33 (1)
68 – – + + + – – – – – – 209 (1)
69 – – + + – – – – – – – 81 (1)
70 – – + – – + + – – – + 87 (1)
71 – + + – – + – + + – + 83 (1)
aThe numbering of the SAg profiles follows the one adopted previously (Friães et al., 2013a,b; Silva-Costa et al., 2014).
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FIGURE 2 | Nucleotide alterations identified in the covR (A), covS (B), and ropB (C) alleles among skin and soft tissue isolates with no detectable SpeB (n = 79),
relative to the alleles present in strain SF370 (AE004092). Each gene is indicated by a gray arrow with the respective numbering scale below. Each sequence variation
is indicated in the respective nucleotide position by a letter corresponding to the variant nucleotide, or the sequence or number of base-pairs inserted (ins), deleted
(del), or duplicated (dup). Synonymous changes are represented in black; missense mutations and in-frame indels are represented in blue. Changes predicted to result
in null alleles, including nonsense mutations and indels that generate frameshifts are represented in red. One exception is represented by “*” corresponding to an
isolate with an early deletion of 4 bp in ropB which is more probable to result in the alteration of the start codon rather than a premature stop codon and therefore was
not considered as a null mutation.
DISCUSSION
Antimicrobial resistance among SSTI isolates was not
significantly different from that found among contemporary
iGAS and pharyngitis isolates, with the decreasing resistance to
macrolides in SSTI mirroring declines in resistance previously
described among isolates causing these other infections (Friães
et al., 2013b; Silva-Costa et al., 2015).
The studied SSTI isolates presented a very high genetic
diversity, which was higher than the diversity of iGAS isolates in
the period of 2005–2009. Still, two lineages accounted for more
than one third of all SSTI isolates, namely emm89 and emm1. The
molecular epidemiology of SSTI GAS isolates varies considerably
among the different published studies, but these often refer to
distinct time periods than the one studied here and include
different infection types, with some including only isolates from
impetigo, while others, like the present study, include all SSTI
isolates. In Finland, a clear dominance of emm77 (40%) was
found among pus isolates from 2008, followed by emm types 1,
28, and 89 (13%) (Vähäkuopus et al., 2012). In Northern Spain,
emm77 was the second more prevalent type (17%) among dermal
infections during 2005–2011, but emm89 largely dominated
(31%) (Tamayo et al., 2014). In Norway, skin isolates recovered
between 2005 and 2006 were dominated by emm types 28, 12, and
87 (Kittang et al., 2008), and in Serbia emm58 was significantly
associated with SSTI, comprising 12 of the 52 SSTI isolates
recovered in 2001–2007 (Mijač et al., 2010). In Beijing, among 52
impetigoGAS isolated between 2005 and 2008, emm12 and emm1
were highly prevalent (54 and 37%, respectively) (Liang et al.,
2005). In Japan, emm28 was the most prevalent (23%) among
53 abscess isolates during 2003–2006 (Wajima et al., 2008),
while in Taiwan a high prevalence of emm11 and emm106 was
reported among isolates from different types of SSTI (Chiang-
Ni et al., 2011; Lin et al., 2011). A very high diversity was
observed among isolates recovered from pyoderma in India and
in the Aboriginal Australian communities, presenting emm types
infrequently isolated in developed, temperate climate regions
(McDonald et al., 2007; Kumar et al., 2012).
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In our study, although most of the emm types were identified
among both iGAS and SSTI isolates, there were clear differences
in the overall emm and clonal distribution between the two
infections. The emm type 1 associated to iGAS was also
previously found to be overrepresented among iGAS relative
to pharyngitis (Friães et al., 2012), confirming the enhanced
capacity of this lineage to cause invasive disease. The emm1
isolates have remained a major cause of iGAS in Portugal
from 2000 to 2009 (Friães et al., 2007, 2013b), in line with
the worldwide dissemination of the M1T1 clone (O’Loughlin
et al., 2007; Aziz and Kotb, 2008; Luca-Harari et al., 2009). The
association between emm3 and iGAS is not unexpected, since
emm3 has been reported as a major cause of invasive disease
in Portugal and other countries, although the comparison with
pharyngitis isolates did not identify this emm type (Beres et al.,
2004; Luca-Harari et al., 2009; Friães et al., 2013b).
The association between emm89 and SSTI has been previously
reported in Northern Spain, but with no information regarding
the specific clades involved (Tamayo et al., 2014). In Finland,
emm89 was not particularly associated with SSTI, although it
was among the most frequent emm types in isolates recovered
from pus (Vähäkuopus et al., 2012). However, the Finish study
refers to 2008, prior to the emergence of emm89 clade 3 in
Finland, at least among GAS isolated from blood (Latronico
et al., 2016). In Portugal, only emm89 isolates lacking the hasABC
locus, presumed to belong to the recently emerged clade 3 (Friães
et al., 2015a; Zhu et al., 2015), were significantly associated with
SSTI. This observation is in line with the previously reported
increase in the prevalence of emm89 among SSTI in Portugal,
but not in iGAS or pharyngitis, associated with the emergence
of this acapsular clade (Friães et al., 2015a). In agreement,
between 2005 and 2009 the increase of emm89 isolates lacking
the capsule locus translated into a significant increase of emm89
isolates only among SSTI, but not among iGAS. Our data thus
raises the possibility that the genome remodeling underlying
the emergence of emm89 clade 3 may have led to a particular
propensity to cause SSTI, although this clade also quickly
replaced the previously circulating emm89 clades in all infection
types (Friães et al., 2015a). This association with SSTI could be
due to an increased capacity to colonize the skin, as well as to an
improved ability to overcome themajor host defensemechanisms
present in skin and soft tissue or to produce cytotoxic effects
at these sites. Increased transmissibility and persistence has
been suggested for clade 3-associated strains based on enhanced
capacity to adhere to uncoated plastic (Turner et al., 2015), while
the increased expression of NADase and SLO by clade 3 has
been associated with virulence in a mouse model of necrotizing
fasciitis (Zhu et al., 2015). However, further investigation is
needed to clarify the role of these phenotypes in the specific
association of emm89 clade 3 with SSTI.
These associations between emm type and disease
presentation were reflected on the different prevalence of
the respective STs and SAg profiles between iGAS and SSTI,
in agreement with the high congruence previously observed
between these three typing methods (Carriço et al., 2006; Friães
et al., 2013a). The observed association of emm clusters A-C3
and A-C5 with iGAS, as well as that of cluster E4 with SSTI also
reflects the association of the respective emm types with the types
of infection.
According to the predicted ability of the different M proteins
to interact with host factors (Sanderson-Smith et al., 2014),
invasive isolates would be associated with the ability to bind
fibrinogen and albumin. The ability to bind fibrinogen was
proposed as a mechanism to decrease complement deposition
resulting from the activation of the classical pathway (Carlsson
et al., 2005). A similar function is believed to be performed by
C4BP (Carlsson et al., 2003), whose binding was associated with
SSTI isolates due to the high prevalence of emm clusters E3
and E6 in this type of infection. The reasons why complement
inhibition could be achieved through fibrinogen in iGAS and
C4BP recruitment in SSTI remain elusive. Most emm clusters
include proteins able to bind albumin, with the exception
of cluster E4 (Sanderson-Smith et al., 2014). The association
of cluster E4 with SSTI resulted in the overrepresentation
of albumin binding among iGAS. Although albumin binding
was shown to mask epitopes in the C-repeated region of
the M protein (Sandin et al., 2006), deletion of this region
did not impair virulence in a mouse intraperitoneal infection
model (Waldemarsson et al., 2009), not providing clues as to
why this could be important in the context of iGAS. The
ability to bind to human IgA and IgG was associated with
SSTI isolates. Immunoglobulin binding was shown to hinder
opsonophagocytosis, even in the absence of a specific immune
response (Carlsson et al., 2003). One can imagine such defense
mechanism could be useful to bacteria in the context of both SSTI
and iGAS and the reasons for the observed differences deserve
further scrutiny. Only 5% of the SSTI isolates were predicted to
bind plasminogen, although this was recently shown to facilitate
keratinocyte invasion (Siemens et al., 2011) and could thus be
beneficial in the context of SSTI.
The acquisition of mutations in the two-component
regulatory system CovRS is regarded as an important mechanism
promoting the transition to an invasive phenotype among GAS
isolates. Current data suggests that upon infection with a wild
type strain, covRS mutants arise at the focal infection site, from
which mixed populations are recovered, and are subsequently
selected for during transition to deeper, normally sterile sites
(Sumby et al., 2006; Mayfield et al., 2014). In our previous
work, we observed that null covS alleles were significantly
overrepresented among iGAS (10%) relative to pharyngeal
isolates (2%) (Friães et al., 2015b). Despite the low number of
isolates carrying covS null alleles in all types of infection, the
data reported here reveals an underrepresentation of covS null
alleles in SSTI (3%) relative to iGAS isolates (p = 0.009), but no
significant difference relative to pharyngeal isolates. Since our
isolates were obtained from a single colony from each patient,
there was a sampling of possibly mixed populations, which
could introduce a bias or at least underestimate the ongoing
selection of covRS impaired variants. Still we do not believe this
compromises our conclusions since the colonies were randomly
picked without particular care to select any of the variants.
Our results therefore indicate that mutations impairing CovRS
are a hallmark of iGAS isolates, although they still represent a
minority of iGAS (Friães et al., 2015b). The lower prevalence of
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covS null alleles among pharyngeal and SSTI isolates supports
the importance of a functional CovRS in the initial stages of
non-invasive infection, both in skin and in the upper respiratory
tract (Hollands et al., 2010; Alam et al., 2013). As reported for
pharyngeal and invasive isolates (Friães et al., 2015b), covRS
and ropB mutations occurred in SSTI isolates of diverse lineages
and were not a particular characteristic of any specific clone. In
contrast to covS, the proportion of ropB null alleles among SSTI
isolates (4%) was similar to that found among both pharyngeal
and invasive isolates (3%), indicating that mutations abrogating
RopB activity occur in a low fraction of GAS isolates, regardless
of the type of infection they cause.
The approach of considering as null alleles only those
with premature stop codons can potentially underestimate
the number of isolates with non-functional regulators, since
some amino acid substitutions may also inactivate protein
function. However, this conservative approach was based on
the difficulty of confidently predicting the functional effect
of missense mutations in covRS and ropB. Several studies
have established an association between specific amino acid
substitutions and an altered phenotype, such as reduced/absent
SpeB or enhanced expression of hyaluronic acid capsule (mucoid
colonies), SLO or NADase (Sumby et al., 2006; Hasegawa
et al., 2010; Ikebe et al., 2010; Carroll et al., 2011; Olsen
et al., 2012; Tatsuno et al., 2013). However, without functional
studies comparing the phenotypes of the isolates with missense
mutations and those of isogenic strains carrying the wild-
type regulator genes, it is not possible to establish causality
between the missense mutations and the complete loss of
CovRS or RopB function. For a few mutations this correlation
was further supported by the reversion of the phenotype
after complementation with wild-type covRS genes (Engleberg
et al., 2001; Masuno et al., 2014), but those mutations were
not identified in our study. On the other hand, it has been
shown that amino acid substitutions in CovS may result in
a partial function loss (Tatsuno et al., 2013) and that the
reduction in the kinase or phosphatase activity of CovS has
different effects in the transcriptomes of strains from distinct
lineages (Horstmann et al., 2015). Likewise, some ropB missense
mutations that were identified in multiple strains were associated
with different levels of SpeB expression and activity (Olsen et al.,
2012).
The abrogation of SpeB activity is usually regarded as one
of the most important features of CovRS mutants contributing
to the invasive phenotype, since this abrogation spares multiple
virulence factors involved in invasive disease pathogenesis and
evasion of host immunity (Carroll and Musser, 2011). The
proportion of isolates lacking SpeB among our SSTI collection
(25%) was similar to that found previously among iGAS (24%)
and higher, but not significantly, than that found among
pharyngitis isolates in Portugal (16%, p = 0.081) (Friães et al.,
2015b). Only one ST was associated with a lack of SpeB
expression (ST382) and both this ST and the emm type it
expresses (emm6) were evenly distributed in both SSTI and iGAS.
These results suggest that, in addition to SpeB downregulation,
the differential regulation of other virulence genes induced by
impairment of CovRS is also critical for an enhanced invasive
capacity of the isolates. In agreement with this suggestion, a
mouse model of SSTI showed that covRS mutants produced
larger necrotic regions than speB mutants (Engleberg et al.,
2004).
A limitation of this study is the lack of information regarding
the specific infection caused by the isolates, as well as the
clinical evolution and outcome of each infection. SSTI include
a wide range of superficial and deep infections which vary greatly
in severity. It was therefore not possible to evaluate possible
correlations between the clones identified in SSTI and the severity
of the respective infections. This could bias the comparison
between SSTI and iGAS, leading to a possible underestimation
of the differences between the two types of infection. However,
even in these conditions we still identified significant differences
between the two subsets of isolates regarding both clonal
composition and presence of null covS alleles, which are in
agreement with our previous observations from the comparison
between pharyngeal and iGAS isolates (Friães et al., 2012, 2015b).
GAS isolates causing SSTI in Portugal are a genetically diverse
population. Still, the 30 valent M protein-based vaccine, which
was shown to evoke cross-opsonic antibodies against non-
vaccine serotypes (Dale et al., 2011), could potentially cover
up to 95% of SSTI in Portugal. Although SSTI are the main
primary foci associated with invasive disease (Lamagni et al.,
2008), SSTI isolates, inasmuch as pharyngeal isolates (Friães
et al., 2012), present a clearly different clonal composition from
contemporary iGAS isolates. It is less clear how the differences in
the presumed interaction with host proteins and exotoxin profiles
brought about by those clonal differences could explain the
distinct disease presentations. Despite the different prevalence
of multiple emm types between SSTI and iGAS, within each
emm type the same MLST defined lineages and the same SAg
profiles could be found in both infection types. This indicates
that any intra-emm type genetic differences between the two
populations must be explored at a more detailed level, such as by
whole-genome sequencing. Our current data therefore indicates
that among the GAS clones causing infection in the Portuguese
population, some have an increased capacity to invade deeper
tissues and cause severe infections, while others seem to
be particularly successful at establishing SSTI or pharyngeal
infections. The proportion of SSTI isolates with no detectable
SpeB activity was modest and similar to that found previously
in Portugal among iGAS and pharyngitis isolates, indicating that
the selective pressure to eliminate SpeB is also not a primary
factor in SSTI. However, we confirmed an association between
mutations abrogating CovRS function and iGAS, suggesting
that increased expression of other virulence factors, such as the
hyaluronic acid capsule, streptolysins or NADase, rather than
SpeB downregulation, may be under selection in the context of
iGAS.
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